{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:12:53Z","timestamp":1775182373316,"version":"3.50.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhenjiang Science and Technology Plan Project","award":["SH2024013"],"award-info":[{"award-number":["SH2024013"]}]},{"name":"Zhenjiang Science and Technology Plan Project","award":["SH2024018"],"award-info":[{"award-number":["SH2024018"]}]},{"name":"Zhenjiang Science and Technology Plan Project","award":["JC2024042"],"award-info":[{"award-number":["JC2024042"]}]},{"name":"Zhenjiang Science and Technology Plan Project","award":["JC2024043"],"award-info":[{"award-number":["JC2024043"]}]},{"name":"Jiangsu Natural Science Foundation Youth Project","award":["BK20240506"],"award-info":[{"award-number":["BK20240506"]}]},{"name":"Research Foundation of Jiangsu provincial commission of health and family planning","award":["H2023036"],"award-info":[{"award-number":["H2023036"]}]},{"name":"Research Foundation of Jiangsu provincial commission of health and family planning","award":["H2024099"],"award-info":[{"award-number":["H2024099"]}]},{"name":"Clinical Medical Research Conversion Special"},{"name":"Anhui Key Research and Development Program","award":["202204295107020065"],"award-info":[{"award-number":["202204295107020065"]}]},{"name":"Science and Technology Key Project of Quzhou","award":["2024\u00a0K120"],"award-info":[{"award-number":["2024\u00a0K120"]}]},{"name":"Science and Technology Key Project of Quzhou","award":["2024\u00a0K121"],"award-info":[{"award-number":["2024\u00a0K121"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Hyperprolactinemia and altered prolactin (PRL) levels are well-documented in schizophrenia. However, very few studies have investigated sex-specific differences in the prevalence of PRL disturbances in first-episode patients with schizophrenia. This cross-sectional study investigated sex-specific PRL dysregulation and its interplay with gonadal hormones in first-episode schizophrenia (FES) patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>One hundred eighty-nine first-episode patients (96 males, 93 females) with minimally treated (\u22642\u00a0weeks) were recruited. PRL levels and gonadal hormones were measured in all participants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We found a significantly higher prevalence of abnormal PRL levels in males compared to females (32.3% vs 8.6%, \u03c72\u2009=\u200916.2, P &amp;lt; .001). Comparative analysis of gonadal hormones between elevated PRL (n\u2009=\u200939) and normal PRL (n\u00a0=\u2009150) groups demonstrated elevated follicle-stimulating hormone (Z\u2009=\u20092.7, P = .007) and testosterone (Z\u2009=\u20093.7, P &amp;lt; .001) in the hyperprolactinemic group. In the elevated PRL group, PRL positively correlated with progesterone and testosterone, whereas in the normal PRL group, PRL showed positive associations with estradiol and luteinizing hormone, but negative correlations with progesterone.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our findings underscore the complex and sex-specific nature of PRL dysregulation and its association with gonadal hormones in FES patients.<\/jats:p>\n                  <jats:p>Significance Statement This work analyses the sex-specific pattern of prolactin (PRL) disturbance in antipsychotic-na\u00efve or minimally treated first-episode schizophrenia (FES), the earliest clinical manifestation of the disorder. While hyperprolactinemia is well documented, its sex-stratified links to gonadal hormones at illness onset remain unclear. We therefore reassessed PRL and gonadal hormone levels in 189 drug-na\u00efve or minimally treated FES patients. Results showed that abnormal PRL levels were almost four times more common in males than in females. Hyperprolactinemic patients displayed elevated testosterone and follicle-stimulating hormone, whereas normal-PRL patients exhibited inverse PRL-progesterone relationships. These findings reveal a sex-divergent neuroendocrine signature at psychosis onset, underscoring the need for sex-specific endocrine monitoring and personalized early intervention strategies that target PRL-gonadal hormone pathways.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ijnp\/pyaf068","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T18:11:56Z","timestamp":1758305516000},"source":"Crossref","is-referenced-by-count":1,"title":["Sex-specific prolactin disturbance and divergent gonadal hormone correlates in first-episode schizophrenia"],"prefix":"10.1093","volume":"28","author":[{"given":"Anle","family":"Pan","sequence":"first","affiliation":[{"name":"The Second People's Hospital of Lishui, Zhejiang \u00a0 Provincial Clinical Research Center for Mental Disorders, Zhejiang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jindong","family":"Wang","sequence":"additional","affiliation":[{"name":"Qingdao Mental Health Center ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liang","sequence":"additional","affiliation":[{"name":"Qingdao Mental Health Center ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5125-8429","authenticated-orcid":false,"given":"Meihong","family":"Xiu","sequence":"additional","affiliation":[{"name":"Peking University HuiLongGuan Clinical Medical School, Beijing \u00a0 Huilongguan Hospital, Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7292-7788","authenticated-orcid":false,"given":"Qiang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Zhenjiang Mental Health Center, Zhenjiang, Jiangsu Province ,","place":["China"]},{"name":"Department of Psychiatry , Wuhu Hospital of Anding Hospital (The Fourth People's Hospital of Wuhu), Anhui,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The Third Hospital of Quzhou, Quzhou, Zhejiang Province ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,13]]},"reference":[{"key":"2025101309364581500_ref1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.MS21078COM5","article-title":"The epidemiology and global burden of schizophrenia","volume":"84","author":"Velligan","year":"2023","journal-title":"J Clin Psychiatry"},{"key":"2025101309364581500_ref2","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/brainsci11101298","article-title":"HPA axis in the pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation","volume":"11","author":"Mikulska","year":"2021","journal-title":"Brain sciences"},{"key":"2025101309364581500_ref3","doi-asserted-by":"publisher","first-page":"106371","DOI":"10.1016\/j.psyneuen.2023.106371","article-title":"The neural, stress hormone and inflammatory correlates of childhood deprivation and threat in psychosis: a systematic review","volume":"157","author":"Thomas","year":"2023","journal-title":"Psychoneuroendocrinology."},{"key":"2025101309364581500_ref4","first-page":"421","article-title":"The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review","volume-title":"CNS Drugs","author":"Peuskens","year":"2014"},{"key":"2025101309364581500_ref5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.schres.2021.08.013","article-title":"Prolactin levels influenced by antipsychotic drugs in schizophrenia: a systematic review and network meta-analysis","volume":"237","author":"Zhu","year":"2021","journal-title":"Schizophr Res"},{"key":"2025101309364581500_ref6","doi-asserted-by":"crossref","first-page":"106049","DOI":"10.1016\/j.psyneuen.2023.106049","article-title":"Prolactin and morning cortisol concentrations in antipsychotic na\u00efve first episode psychosis: a systematic review and meta-analysis","volume":"150","author":"Aymerich","year":"2023","journal-title":"Psychoneuroendocrinology."},{"key":"2025101309364581500_ref7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.schres.2016.03.018","article-title":"Prolactin concentrations in antipsychotic-na\u00efve patients with schizophrenia and related disorders: a meta-analysis","volume":"174","author":"Gonz\u00e1lez-Blanco","year":"2016","journal-title":"Schizophr Res"},{"key":"2025101309364581500_ref8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12888-018-1827-3","article-title":"Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis","volume":"18","author":"Petruzzelli","year":"2018","journal-title":"BMC Psychiatry"},{"key":"2025101309364581500_ref9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3389\/fpsyt.2020.00775","article-title":"Glucose metabolism, thyroid function, and prolactin level in adolescent patients with first episode of schizophrenia and affective disorders","volume":"11","author":"Petruzzelli","year":"2020","journal-title":"Front Psychiatry"},{"key":"2025101309364581500_ref10","doi-asserted-by":"publisher","first-page":"106392","DOI":"10.1016\/j.psyneuen.2023.106392","article-title":"Blood concentrations of anterior pituitary hormones in drug-na\u00efve people with first-episode psychosis: a systematic review and meta-analysis","volume":"158","author":"Cavaleri","year":"2023","journal-title":"Psychoneuroendocrinology."},{"key":"2025101309364581500_ref11","first-page":"e785","article-title":"Dopamine\u2013prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity","volume-title":"Transl Psychiatry","author":"Gragnoli","year":"2016"},{"key":"2025101309364581500_ref14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/0269881112442016","article-title":"Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis","volume":"26","author":"Cookson","year":"2012","journal-title":"J Psychopharmacol"},{"key":"2025101309364581500_ref15","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol Rev"},{"key":"2025101309364581500_ref16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1176\/appi.ajp.159.5.713","article-title":"Schizophrenia: reproductive hormones and the brain","volume":"159","author":"Stevens","year":"2002","journal-title":"Am J Psychiatry"},{"key":"2025101309364581500_ref17","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyae063","article-title":"Gonadal hormone abnormalities in young patients with first-episode schizophrenia","volume":"27","author":"Hu","year":"2024","journal-title":"Int J Neuropsychopharmacol"},{"key":"2025101309364581500_ref18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.schres.2006.02.008","article-title":"Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia","volume":"84","author":"Akhondzadeh","year":"2006","journal-title":"Schizophr Res Treat"},{"key":"2025101309364581500_ref19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5455\/apd.119468","article-title":"Relationship between gonadal hormone levels and symptom severity in female patients with schizophrenia","volume":"22","author":"Sezer","year":"2021","journal-title":"Alpha Psychiatry"},{"key":"2025101309364581500_ref20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.comppsych.2016.06.005","article-title":"The relationship between sex hormone profiles and symptoms of schizophrenia in men","volume":"69","author":"Bulut","year":"2016","journal-title":"Compr Psychiatry"},{"key":"2025101309364581500_ref21","doi-asserted-by":"crossref","first-page":"615356","DOI":"10.1155\/2015\/615356","article-title":"A role for estrogen in schizophrenia: clinical and preclinical findings","volume":"2015","author":"Gogos","year":"2015","journal-title":"Int J Endocrinol"},{"key":"2025101309364581500_ref22","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00737-023-01409-x","article-title":"Estrogen and psychosis\u2014a review and future directions","volume":"27","author":"Mu","year":"2024","journal-title":"Arch Womens Ment Health"},{"key":"2025101309364581500_ref23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/YCO.0000000000000699","article-title":"Estrogens in schizophrenia: progress, current challenges and opportunities","volume":"34","author":"Brand","year":"2021","journal-title":"Curr Opin Psychiatry"},{"key":"2025101309364581500_ref24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/npr2.12190","article-title":"Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels","volume":"41","author":"Tasaki","year":"2021","journal-title":"Neuropsychopharmacol Rep"},{"key":"2025101309364581500_ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2024.03.002","article-title":"Sex-specific associations between sex hormones and clinical symptoms in late-life schizophrenia","volume":"267","author":"Li","year":"2024","journal-title":"Schizophr Res Treat"},{"key":"2025101309364581500_ref26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fpsyt.2020.00693","article-title":"Schizophrenia and sex hormones: what is the link?","volume":"11","author":"Brzezinski-Sinai","year":"2020","journal-title":"Front Psychiatry"},{"key":"2025101309364581500_ref27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00737-017-0787-9","article-title":"A systematic review of cortisol, thyroid-stimulating hormone, and prolactin in peripartum women with major depression","volume":"21","author":"Szpunar","year":"2018","journal-title":"Arch Womens Ment Health"},{"key":"2025101309364581500_ref28","first-page":"2203","article-title":"Hyperprolactinaemia","volume-title":"J Clin Med","author":"Samperi","year":"2019"},{"key":"2025101309364581500_ref29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0306-4530(02)00112-9","article-title":"Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology."},{"key":"2025101309364581500_ref30","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1365-2826.2008.01736.x","article-title":"Prolactin: a pleiotropic neuroendocrine hormone","volume":"20","author":"Grattan","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"2025101309364581500_ref31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1507\/endocrj.K09E-185","article-title":"GnRH pulsatility, the pituitary response and reproductive dysfunction","volume":"56","author":"Tsutsumi","year":"2009","journal-title":"Endocr J"},{"key":"2025101309364581500_ref32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ar.1092310408","article-title":"Gonadotropin-releasing hormone mRNA in the rat: distribution and neuronal content over the estrous cycle and after castration of males","volume":"231","author":"Malik","year":"1991","journal-title":"Anat Rec"},{"key":"2025101309364581500_ref33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/13651501.2016.1197274","article-title":"Prolactin levels in drug-na\u00efve patients with schizophrenia and other psychotic disorders","volume":"20","author":"Petrikis","year":"2016","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2025101309364581500_ref34","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0149-2918(00)80086-7","article-title":"The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia","volume":"22","author":"David","year":"2000","journal-title":"Clin Ther"},{"key":"2025101309364581500_ref36","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet."},{"key":"2025101309364581500_ref37","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.pnpbp.2010.02.019","article-title":"Hyperprolactinaemia in early psychosis-not only due to antipsychotics","volume":"34","author":"Aston","year":"2010","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2025101309364581500_ref38","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1017\/S0033291713000226","article-title":"Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis","volume":"43","author":"Riecher-R\u00f6ssler","year":"2013","journal-title":"Psychol Med"},{"key":"2025101309364581500_ref39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.schres.2011.07.025","article-title":"Prolactin concentrations in newly diagnosed, antipsychotic-na\u00efve patients with nonaffective psychosis","volume":"134","author":"Garcia-Rizo","year":"2012","journal-title":"Schizophr Res"},{"key":"2025101309364581500_ref40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S2215-0366(16)30379-0","article-title":"Oestrogens, prolactin, hypothalamic-pituitary-gonadal axis, and schizophrenic psychoses","volume":"4","author":"Riecher-R\u00f6ssler","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"2025101309364581500_ref41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0032-1312592","article-title":"Sex, stress, and mood disorders: at the intersection of adrenal and gonadal hormones","volume":"44","author":"Fernandez-Guasti","year":"2012","journal-title":"Horm Metab Res"},{"key":"2025101309364581500_ref42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/BF03348463","article-title":"Effects of stress on the gonadal function","volume":"7","author":"Collu","year":"1984","journal-title":"J Endocrinol Investig"},{"key":"2025101309364581500_ref43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/2230-8210.77573","article-title":"Stress and hormones","volume":"15","author":"Ranabir","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"2025101309364581500_ref44","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.psyneuen.2011.04.007","article-title":"Prolactin in response to acute psychosocial stress in healthy men and women","volume":"36","author":"Lennartsson","year":"2011","journal-title":"Psychoneuroendocrinology."},{"key":"2025101309364581500_ref45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jpsychires.2014.10.011","article-title":"Stress biomarkers as predictors of transition to psychosis in at-risk mental states: roles for cortisol, prolactin and albumin","volume":"60","author":"Labad","year":"2015","journal-title":"J Psychiatr Res"},{"key":"2025101309364581500_ref46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/REP-06-0299","article-title":"Reproductive role of prolactin","volume":"133","author":"Bachelot","year":"2007","journal-title":"Reproduction."}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyaf068\/64260922\/pyaf068.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/28\/10\/pyaf068\/64260922\/pyaf068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/28\/10\/pyaf068\/64260922\/pyaf068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:40:15Z","timestamp":1760362815000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/doi\/10.1093\/ijnp\/pyaf068\/8253410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,13]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyaf068","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,13]]},"article-number":"pyaf068"}}